Bank of New York Mellon’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Bank of New York Mellon's GRNA Position: Q3 2023 in Review

Bank of New York Mellon sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 25,126 shares — an estimated $7.49K sold.

Bank of New York Mellon first reported a position in GRNA in Q1 2022 and held it in 6 quarters. The position peaked at $495K in Q3 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

• Bank of New York Mellon reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
• Bank of New York Mellon sold 25,126 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $7.49K.
• Bank of New York Mellon first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 6 quarters.
• Bank of New York Mellon's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $495K in Q3 2022.
• 0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.